XRCC6 and neoplasm: Gene chip analysis combined with experimental verification has confirmed that PARP6 inhibits XRCC6 expression by inducing its degradation, thereby suppressing the Wnt/β‐catenin pathway, which contributes to tumor suppression in HCC.